Evidence map›Paper›PMID 30389208›Full record

ArticleJournal of chromatography. A2018

Fast, selective and quantitative protein profiling of adenovirus-vector based vaccines by ultra-performance liquid chromatography.

Ewoud van Tricht, Pascal de Raadt, Annemiek Verwilligen, Martijn Schenning, Harold Backus, Marta Germano, Govert W Somsen, Cari E Sänger-van de Griend

Open access · greenAbstract read
In one paragraph

Article in Journal of chromatography. A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ewoud van TrichtJanssen Vaccines and Prevention, Pharmaceutical and Analytical Development, Newtonweg 1, 2333 CP Leiden, The Netherlands. Electronic address: evantri@its.jnj.com.
Pascal de RaadtJanssen Vaccines and Prevention, Pharmaceutical and Analytical Development, Newtonweg 1, 2333 CP Leiden, The Netherlands.
Annemiek VerwilligenJanssen Vaccines and Prevention, Pharmaceutical and Analytical Development, Newtonweg 1, 2333 CP Leiden, The Netherlands.
Martijn SchenningJanssen Vaccines and Prevention, Pharmaceutical and Analytical Development, Newtonweg 1, 2333 CP Leiden, The Netherlands.
Harold BackusJanssen Vaccines and Prevention, Pharmaceutical and Analytical Development, Newtonweg 1, 2333 CP Leiden, The Netherlands.
Marta GermanoJanssen Vaccines and Prevention, Pharmaceutical and Analytical Development, Newtonweg 1, 2333 CP Leiden, The Netherlands.
Govert W SomsenVrije Universiteit Amsterdam, Divison of BioMolecular Analysis, Amsterdam Institute of Molecules, Medicines and Systems, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands.
Cari E Sänger-van de GriendKantisto BV, Callenburglaan 22, 3742 MV Baarn, The Netherlands; Uppsala University, Faculty of Pharmacy, Department of Medicinal Chemistry, Biomedical Centre PO Box 574, SE-751 23 Uppsala, Sweden.
Janssen (Netherlands) · NLUppsala University · SEVrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A method for the quantitative determination of the protein composition of adenovirus-vector based vaccines was developed. The final method used RP-UPLC with UV absorbance detection, a C4 column (300 Å, 1.7 μm, 2.1 × 150 mm), and a water- acetonitrile (ACN) gradient containing trifluoroacetic acid (TFA) as ion-pairing agent. The chromatographic resolution between the various adenovirus proteins was optimized by studying the effect of the TFA concentration and the column temperature, applying a full factorial design of experiments. A reproducible baseline separation of all relevant adenovirus proteins could be achieved within 17 min run time. Samples containing adenovirus particles could be directly injected into the UPLC system without sample pretreatment. The viruses reproducibly dissociate into proteins in the UPLC system upon contact with the mobile phase containing ACN. The new RP-UPLC method was successfully validated for protein profiling and relative quantification of proteins in vaccine products based on adenovirus vector types 26 and 35. The intermediate precision of the relative peak areas of all proteins was between 1% and 14% RSD, except for the peak assigned to protein V (26% RSD). The method proved to be stability indicating with respect to thermal and oxidation stress of the adenovirus-vector based vaccine and was successfully implemented for the characterization of adenovirus-based products.

Indexed as

Chromatography, High Pressure LiquidAdenovirus VaccinesChemistry Techniques, AnalyticalLimit of DetectionProteinsTemperatureAdenovirus VaccinesProteinsAdenovirusIntact proteinsProtein profilingQuantificationRP-UPLC

Identifiers

PMID30389208
PMCPMC7094600
OpenAlexW2898434193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.